Literature DB >> 27037225

The use of systemic antibiotics in the treatment of refractory periodontitis: A systematic review.

Rayane S Santos, Rodrigo F Macedo, Emmanuel A Souza, Renata S C Soares, Daniela S Feitosa, Carlos F M Sarmento.   

Abstract

BACKGROUND: The goal in treating refractory periodontitis (RP) is to arrest or slow disease progression, which usually has included the use of systemic antibiotics adjunct to conventional mechanical debridement. The aim of this systematic review was to evaluate the evidence that the association of systemic antibiotics with conventional mechanical debridement increases the efficacy of periodontal therapy in the treatment of RP. TYPES OF STUDIES REVIEWED: The authors searched for studies in PubMed MEDLINE, Cochrane Central Register of Controlled Trials, Thomson Reuters Web of Science, Scopus, Latin American and Caribbean Center on Health Sciences Information, and Scientific Electronic Library Online electronic databases by using selected key words from the earliest records up through October 31, 2014. Only clinical intervention studies in which investigators compared the treatment of participants with RP with either mechanical debridement alone or associated with systemic antibiotics were eligible for selection. Two authors independently assessed the risk of bias of each selected study.
RESULTS: The authors identified 13 articles and included 6 of them. Investigators in all studies reported greater reductions in probing depth or in loss of clinical attachment level after adjunct systemic antibiotic therapy when compared with mechanical debridement alone. Antibiotics tested included metronidazole, clindamycin, tetracycline hydrochloride, amoxicillin, and amoxicillin and potassium clavulanate. Five studies presented a high risk of bias, and 1 study presented an unclear risk. CONCLUSIONS AND PRACTICAL IMPLICATIONS: The overall quality of the evidence does not allow the conclusion that adjunct systemic antibiotics are of additional benefit to conventional mechanical debridement alone.
Copyright © 2016 American Dental Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Periodontitis; periodontal treatment; systemic antibiotic therapy

Mesh:

Substances:

Year:  2016        PMID: 27037225     DOI: 10.1016/j.adaj.2016.02.013

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  6 in total

1.  Amixicile depletes the ex vivo periodontal microbiome of anaerobic bacteria.

Authors:  Qin Gui; Kane W Ramsey; Paul S Hoffman; Janina P Lewis
Journal:  J Oral Biosci       Date:  2020-04-09

2.  Effect of Locally Delivered Minocycline on the Profile of Subgingival Bacterial Genera in Patients with Periodontitis: A Prospective Pilot Study.

Authors:  Toshiya Morozumi; Yohei Nakayama; Satoshi Shirakawa; Kentaro Imamura; Kaname Nohno; Takatoshi Nagano; Haruna Miyazawa; Takahiro Hokari; Ryo Takuma; Shuntaro Sugihara; Kazuhiro Gomi; Atsushi Saito; Yorimasa Ogata; Motohiro Komaki
Journal:  Biomolecules       Date:  2022-05-18

3.  Development of a multicellular 3D-bioprinted microtissue model of human periodontal ligament-alveolar bone biointerface: Towards a pre-clinical model of periodontal diseases and personalized periodontal tissue engineering.

Authors:  Murat Taner Vurat; Şükran Şeker; Özge Lalegül-Ülker; Mahmut Parmaksiz; Ayşe Eser Elçin; Yaşar Murat Elçin
Journal:  Genes Dis       Date:  2020-11-28

4.  Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis.

Authors:  Meng-Hsuan Ho; Richard J Lamont; Walter J Chazin; Huiqing Chen; Daphne F Young; Prashant Kumar; Hua Xie
Journal:  Mol Oral Microbiol       Date:  2018-10-30       Impact factor: 3.563

5.  A novel peptidic inhibitor derived from Streptococcus cristatus ArcA attenuates virulence potential of Porphyromonas gingivalis.

Authors:  Meng-Hsuan Ho; Richard J Lamont; Hua Xie
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

6.  Amixicile, a novel strategy for targeting oral anaerobic pathogens.

Authors:  Justin A Hutcherson; Kathryn M Sinclair; Benjamin R Belvin; Qin Gui; Paul S Hoffman; Janina P Lewis
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.